Viewing StudyNCT06475820

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06475820
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-26
First Post: 2024-05-17
Brief Title: Preventing of GVHD With Post-transplantation Cyclophosphamide Abatacept Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
Sponsor: Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization: Federal Research Institute of Pediatric Hematology Oncology and Immunology
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Biphenotypic Acute Leukemia
Malignant Lymphoma
Myelodysplastic Syndromes
Keywords:
Name View
Hematopoetic stem cell transplantation View
posttransplant cyclophosphamide View
vedolizumab View
hematoblastosis View
ALL View
AML View
children View
young adults View
graft versus host disease View